Naeem W, Nawab F, Sarwar M, Khalil A, Gaber D, Ahmad H
Sci Rep. 2025; 15(1):7896.
PMID: 40050371
PMC: 11885471.
DOI: 10.1038/s41598-025-91700-x.
Funk J, Klimovich M, Drangenstein D, Pielhoop O, Hunold P, Borowek A
Nat Genet. 2025; 57(1):140-153.
PMID: 39774325
PMC: 11735402.
DOI: 10.1038/s41588-024-02039-4.
Klett T, Stahlecker J, Jaag S, Masberg B, Knappe C, Lammerhofer M
ACS Pharmacol Transl Sci. 2024; 7(12):3984-3999.
PMID: 39698266
PMC: 11651176.
DOI: 10.1021/acsptsci.4c00414.
Zhang H, Xu J, Long Y, Maimaitijiang A, Su Z, Li W
Int J Mol Sci. 2024; 25(23).
PMID: 39684639
PMC: 11641486.
DOI: 10.3390/ijms252312928.
Alsulami A
Brief Bioinform. 2024; 25(6).
PMID: 39413799
PMC: 11483132.
DOI: 10.1093/bib/bbae514.
Navigating the complexity of p53-DNA binding: implications for cancer therapy.
Thayer K, Stetson S, Caballero F, Chiu C, Han I
Biophys Rev. 2024; 16(4):479-496.
PMID: 39309126
PMC: 11415564.
DOI: 10.1007/s12551-024-01207-4.
In Silico Screening, Molecular Dynamics Simulation and Binding Free Energy Identify Single-Point Mutations That Destabilize p53 and Reduce Binding to DNA.
Islam S, Hasan M, Alam J, Dey A, Molineaux D
Proteins. 2024; 93(2):498-514.
PMID: 39264222
PMC: 11695177.
DOI: 10.1002/prot.26747.
Multiscale simulations reveal the driving forces of p53C phase separation accelerated by oncogenic mutations.
Yu Y, Liu Q, Zeng J, Tan Y, Tang Y, Wei G
Chem Sci. 2024; 15(32):12806-12818.
PMID: 39148776
PMC: 11323318.
DOI: 10.1039/d4sc03645j.
Geometric deep learning of protein-DNA binding specificity.
Mitra R, Li J, Sagendorf J, Jiang Y, Cohen A, Chiu T
Nat Methods. 2024; 21(9):1674-1683.
PMID: 39103447
PMC: 11399107.
DOI: 10.1038/s41592-024-02372-w.
Functional evaluation of germline TP53 variants identified in Brazilian families at-risk for Li-Fraumeni syndrome.
Abreu R, Pereira A, Rosa M, Ashton-Prolla P, Silva V, Melendez M
Sci Rep. 2024; 14(1):17187.
PMID: 39060302
PMC: 11282216.
DOI: 10.1038/s41598-024-67810-3.
Clinical relevance of double heterozygosity revealed by next-generation sequencing of homologous recombination repair pathway genes in South African breast cancer patients.
van der Merwe N, Buccimazza I, Rossouw B, Araujo M, Ntaita K, Schoeman M
Breast Cancer Res Treat. 2024; 207(2):331-342.
PMID: 38814507
PMC: 11297091.
DOI: 10.1007/s10549-024-07362-2.
A cytosolic mutp53(E285K) variant confers chemoresistance of malignant melanoma.
Dunsche L, Ivanisenko N, Riemann S, Schindler S, Beissert S, Angeli C
Cell Death Dis. 2023; 14(12):831.
PMID: 38097548
PMC: 10721616.
DOI: 10.1038/s41419-023-06360-4.
Elucidating structural variability in p53 conformers using combinatorial refinement strategies and molecular dynamics.
Parves M, Solares M, Dearnaley W, Kelly D
Cancer Biol Ther. 2023; 25(1):2290732.
PMID: 38073067
PMC: 10732606.
DOI: 10.1080/15384047.2023.2290732.
A molecular mechanism for the "digital" response of p53 to stress.
Safieh J, Chazan A, Saleem H, Vyas P, Danin-Poleg Y, Ron D
Proc Natl Acad Sci U S A. 2023; 120(49):e2305713120.
PMID: 38015851
PMC: 10710088.
DOI: 10.1073/pnas.2305713120.
How Driver Oncogenes Shape and Are Shaped by Alternative Splicing Mechanisms in Tumors.
Wojtys W, Oron M
Cancers (Basel). 2023; 15(11).
PMID: 37296881
PMC: 10251868.
DOI: 10.3390/cancers15112918.
Structural assessment of the full-length wild-type tumor suppressor protein p53 by mass spectrometry-guided computational modeling.
Ianni A, Tuting C, Kipping M, Ihling C, Koppen J, Iacobucci C
Sci Rep. 2023; 13(1):8497.
PMID: 37231156
PMC: 10213020.
DOI: 10.1038/s41598-023-35437-5.
Chromatin structure related to oncogenesis.
Matsumoto S, Horikoshi N, Takizawa Y, Kurumizaka H
Cancer Sci. 2023; 114(8):3068-3075.
PMID: 37218420
PMC: 10394151.
DOI: 10.1111/cas.15850.
Targeting p53 pathways: mechanisms, structures, and advances in therapy.
Wang H, Guo M, Wei H, Chen Y
Signal Transduct Target Ther. 2023; 8(1):92.
PMID: 36859359
PMC: 9977964.
DOI: 10.1038/s41392-023-01347-1.
Structural basis for p53 binding to its nucleosomal target DNA sequence.
Nishimura M, Takizawa Y, Nozawa K, Kurumizaka H
PNAS Nexus. 2023; 1(4):pgac177.
PMID: 36714865
PMC: 9802185.
DOI: 10.1093/pnasnexus/pgac177.
Therapeutic Strategies to Activate p53.
Aguilar A, Wang S
Pharmaceuticals (Basel). 2023; 16(1).
PMID: 36678521
PMC: 9866379.
DOI: 10.3390/ph16010024.